Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

GSK Pharma board approves sale of Vemgal facility to Hetero Labs for Rs 180 crores

expresspharmaApril 01, 2021

Tag: GSK , Vemgal , Hetero Labs

PharmaSources Customer Service